JordanMatthewDunitzMD
Pulmonology • Minneapolis, MNCritical Care Medicine, Cystic Fibrosis, Lung Transplantation Medicine, Pleural Disease
UMPhysicians
Dr. Dunitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
University of Minnesota Physicians
516 Delaware Street SE PWB Second floor Clinic 2a
Minneapolis, MN 55455Phone+1 612-626-6100Fax+1 612-625-2174
Education & Training
University of MinnesotaFellowship, Pulmonary Disease and Critical Care Medicine, 1991 - 1994- University of MinnesotaResidency, Internal Medicine, 1988 - 1991
Stony Brook University Health Sciences Center School of MedicineClass of 1988
Certifications & Licensure
MN State Medical License 1993 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis Start of enrollment: 2013 Jun 01
- Mapping Chemical and Microbiological Heterogeneity Throughout Explanted Cystic Fibrosis Lung Specimens Start of enrollment: 2014 Jul 01
Publications & Presentations
PubMed
- 58 citationsPrevalence and factors associated with overweight and obesity in adults with cystic fibrosis: A single-center analysisTasma Harindhanavudhi, Qi Wang, Jordan M. Dunitz, Antoinette Moran, Amir Moheet
Journal of Cystic Fibrosis. 2020-01-01 - 138 citationsEvidence and Role for Bacterial Mucin Degradation in Cystic Fibrosis Airway DiseaseJeffrey M. Flynn, David E. Niccum, Jordan M. Dunitz, Ryan C. Hunter
Plos Pathogens. 2016-08-22 - 102 citationsEffect of preoperative pulmonary artery pressure on early survival after lung transplantation for idiopathic pulmonary fibrosis.Timothy P.M. Whelan, Jordan M. Dunitz, Rosemary F. Kelly, L.B. Edwards, Cynthia Herrington
The Journal of Heart and Lung Transplantation. 2005-09-01
Press Mentions
New FDA-Approved Treatment for Cystic Fibrosis Gives Hope to ThousandsOctober 22nd, 2019
Grant Support
- A Phase 3, International, Multi-Center, Randomized, Double-Blind, Placebo-ControNational Center For Research Resources2009
- A Phase 2A, Randomized, Double-Blind, Placebo-Controlled Study Of VX-770 To EvalNational Center For Research Resources2008–2009
- 08-108: Denufosol Tetrasodium Inhalatoin Solution In Mild CF Lung DiseaseNational Center For Research Resources2007–2009
- A Phase 1, OPEN Label Safety And Tolerability Study Of Oral Theraclec In SubjectNational Center For Research Resources2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
